| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/14/2014 | US8628776 Human binding molecules against enterococci and Staphylococcus |
| 01/14/2014 | US8628775 Methods of reducing T cell-mediated immune responses with multimeric P-selectin and/or E-selectin compounds |
| 01/14/2014 | US8628774 Compositions and methods for treating and diagnosing cancer |
| 01/14/2014 | US8628773 Antigen binding proteins |
| 01/14/2014 | US8628772 Surface protein (HBsAg) variant of the hepatitis B virus |
| 01/14/2014 | US8628771 CA IX-specific inhibitors |
| 01/14/2014 | US8628766 Vaccine for protection against Streptococcus suis bacteria of various serotypes |
| 01/14/2014 | US8628754 Highly efficient delivery of a large therapeutic mass aerosol |
| 01/14/2014 | US8628749 Radioimmunoconjugates and uses thereof |
| 01/14/2014 | CA2561073C Composition and method for cancer treatment |
| 01/14/2014 | CA2538691C Process for producing polysaccharide for conjugate vaccine |
| 01/14/2014 | CA2519875C Method of tumor regression with vegf inhibitors |
| 01/14/2014 | CA2426312C Compositions and methods for modulating rsv infection and immunity |
| 01/14/2014 | CA2402530C Blocking leukocyte emigration and inflammation by interfering with cd99 |
| 01/14/2014 | CA2370252C Cancer treatment with endothelin receptor antagonists |
| 01/09/2014 | WO2014008475A2 Compositions and methods related to viral vaccines |
| 01/09/2014 | WO2014008406A2 The bacterial biofilm matrix as a platform for protein delivery |
| 01/09/2014 | WO2014008385A1 Compositions and methods useful for making orthotopic tumors with controllable metastasis |
| 01/09/2014 | WO2014008283A2 Biodegradable polymeric buffers |
| 01/09/2014 | WO2014008263A2 Paramyxovirus and methods of use |
| 01/09/2014 | WO2014007982A2 C-terminal and central epitope a-beta antibodies |
| 01/09/2014 | WO2014007667A1 Autologous vaccine for treating pulmonary tuberculosis and method for producing same |
| 01/09/2014 | WO2014007513A1 Novel monoclonal antibody binding specifically to dll4 and use thereof |
| 01/09/2014 | WO2014007303A1 Therapeutic method and remedy for htlv-1-associated myelopathy patients |
| 01/09/2014 | WO2014006318A1 Method for producing haemophilus influenzae type b antigens |
| 01/09/2014 | WO2014006262A1 Composition containing polypeptides for the treatment of myiasis |
| 01/09/2014 | WO2014006226A1 MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETO |
| 01/09/2014 | WO2014006217A1 Dimeric protein with triple mutations |
| 01/09/2014 | WO2014006215A1 Hydrogel vaccine formulations |
| 01/09/2014 | WO2014006191A1 Novel prime-boosting regimens involving immunogenic polypeptides encoded by polynucleotides |
| 01/09/2014 | WO2014006124A1 Covalently linked antigen-antibody conjugates |
| 01/09/2014 | WO2014006118A1 Anti-theophylline antibodies and methods of use |
| 01/09/2014 | WO2014006115A1 Combination of a phosphoinositide 3-kinase inhibitor and an inhibitor of the il-8/cxcr interaction |
| 01/09/2014 | WO2014006114A1 New treatment for neurodegenerative diseases |
| 01/09/2014 | WO2014006100A1 Treatment for bone diseases |
| 01/09/2014 | WO2014006082A1 Conjugates containing sequences from placenta growth factor and their use as components of biomaterials and in medicine |
| 01/09/2014 | WO2014006058A1 Method for loading of dendritic cells with class i antigens |
| 01/09/2014 | WO2014006025A2 Marker of pathogenicity in salmonella |
| 01/09/2014 | WO2014006018A1 Production and application of protozoa cultures of histomonas meleagridis (h. meleagridis) |
| 01/09/2014 | WO2014005959A1 Complexes of cytomegalovirus proteins |
| 01/09/2014 | WO2014005958A1 Immunogenic compositions and uses thereof |
| 01/09/2014 | WO2014005683A1 Dna vaccine for use in pancreatic cancer patients |
| 01/09/2014 | WO2014005643A1 Novel prime-boosting regimens involving immunogenic polypeptides encoded by polynucleotides |
| 01/09/2014 | WO2013173256A3 New and improved influenza vaccines |
| 01/09/2014 | WO2013163631A3 Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof |
| 01/09/2014 | WO2013132452A3 Neisseria meningitidis compositions and methods thereof |
| 01/09/2014 | US20140011731 Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof |
| 01/09/2014 | US20140011265 Novel process for preparation of polysaccharides |
| 01/09/2014 | US20140011215 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 01/09/2014 | US20140010847 Materials for treating and preventing mucosa related disease |
| 01/09/2014 | US20140010845 Suppression of a hypersensitivity immune response with unrelated antigen derived from allergen source material |
| 01/09/2014 | US20140010844 Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers |
| 01/09/2014 | US20140010843 Method of detoxification |
| 01/09/2014 | US20140010840 Recombinant mumps virus vaccine |
| 01/09/2014 | US20140010839 Method of screening antiretroviral compounds and vaccine |
| 01/09/2014 | US20140010837 Methods and Compositions for Preventing a Condition |
| 01/09/2014 | US20140010834 Non-pathogenic serotype 4 fowl adenovirus (fadv-4) and viral vector thereof |
| 01/09/2014 | US20140010831 Her-2 peptides |
| 01/09/2014 | US20140010830 Non-Coding Immunomodulatory DNA Construct |
| 01/09/2014 | US20140010828 Uses of immunoconjugates targeting cd138 |
| 01/09/2014 | US20140010827 Antibody formulations |
| 01/09/2014 | US20140010826 Use of DR6 and p75 Antagonists to Promote Survival of Cells of the Nervous System |
| 01/09/2014 | US20140010825 Diagnostic and therapeutic potential of HLA-E monospecific monoclonal IgG antibodies directed against tumor cell surface and soluble HLA-E |
| 01/09/2014 | US20140010823 Method for determining optimum intraocular locations for drug delivery systems |
| 01/09/2014 | US20140010822 Antibody therapeutics with local activity in the digestive tract |
| 01/09/2014 | US20140010821 Use of CD83 in combination therapies |
| 01/09/2014 | US20140010819 Method for correcting immunopathological reactions and a medicament |
| 01/09/2014 | US20140010817 Novel Antibodies and Uses Thereof |
| 01/09/2014 | US20140010812 Modulating agonistic tnfr antibodies |
| 01/09/2014 | US20140010805 Administration of hypoxia activated prodrugs and antiangiogenic agents for the treatment of cancer |
| 01/09/2014 | US20140010804 Combination therapy of an afucosylated cd20 antibody with fludarabine and/or mitoxantrone |
| 01/09/2014 | US20140010798 Albumin fusion proteins |
| 01/09/2014 | US20140010780 Vaccine immunotherapy for immune suppressed patients |
| 01/09/2014 | US20140010779 Vaccine immunotherapy for immune suppressed patients |
| 01/09/2014 | US20140010771 Allantoin-Containing Skin Cream |
| 01/09/2014 | US20140010759 Tumor specific anitbodies and uses therefor |
| 01/09/2014 | CA2878367A1 Novel prime-boosting regimens involving immunogenic polypeptides encoded by polynucleotides |
| 01/09/2014 | CA2878344A1 Complexes of cytomegalovirus proteins |
| 01/09/2014 | CA2878128A1 Hydrogel vaccine formulations |
| 01/09/2014 | CA2878100A1 Conjugates containing sequences from placenta growth factor and their use as components of biomaterials and in medicine |
| 01/09/2014 | CA2878053A1 Method for producing haemophilus influenzae type b antigens |
| 01/09/2014 | CA2877948A1 Paramyxovirus and methods of use |
| 01/09/2014 | CA2877938A1 Dna vaccine for use in pancreatic cancer patients |
| 01/09/2014 | CA2877848A1 Therapeutic method and medicament for htlv-1 associated myelopathy (ham) |
| 01/09/2014 | CA2877539A1 Production and application of protozoa cultures of histomonas meleagridis (h. meleagridis) |
| 01/09/2014 | CA2877516A1 C-terminal and central epitope a-beta antibodies |
| 01/09/2014 | CA2876541A1 Mutant fragments of ospa and methods and uses relating thereto |
| 01/08/2014 | EP2682475A1 Antibody and antigen recognizing tumor-initiating cells and use thereof |
| 01/08/2014 | EP2682457A1 Production and application of protozoa cultures of Histomonas meleagridis (H. meleagridis) |
| 01/08/2014 | EP2682405A1 Tumor necrosis factor- humanized antibody |
| 01/08/2014 | EP2682128A1 Medicinal agent for inhibiting metastasis of malignant tumor |
| 01/08/2014 | EP2682127A1 Vaccine |
| 01/08/2014 | EP2682126A1 GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis |
| 01/08/2014 | EP2681559A1 Peptide-lipid constructs and their use in a fc-function assay |
| 01/08/2014 | EP2681246A2 Tetravalent and mixed head bivalent dengue vaccine |
| 01/08/2014 | EP2681243A2 Anti-il-6 receptor antibodies and methods of use |
| 01/08/2014 | EP2681237A1 Antagonistic dr3 ligands |
| 01/08/2014 | EP2681232A1 Infectious bronchitis virus (ibv) spike protein as subunit vaccine |
| 01/08/2014 | EP2680919A2 Immunologically modified carbon nanotubes for cancer treatment |
| 01/08/2014 | EP2680886A1 Substituted quinoline compounds and methods of use |